ADDED
siga20251231_10k.htm 0001010086 Siga Technologies INC false --12-31 FY 2025 true true true false The full Board receives updates periodically or as needed during the year from the Company s Chief Information Officer and actively participates in discussions with management and amongst themselves regarding cybersecurity risks.
Updates delivered to the full Board typically include discussion of management s actions to identify and detect threats, as well as planned actions in the event of a response or recovery situation.
These updates also typically include a review of any recent enhancements to the Company s defenses and management s progress on its cybersecurity, as well as reports on key performance indicators, test results and related remediation, and recent threats and how the Company is managing those threats.
The full Board receives updates periodically or as needed during the year from the Company s Chief Information Officer and actively participates in discussions with management and amongst themselves regarding cybersecurity risks.
Updates delivered to the full Board typically include discussion of management s actions to identify and detect threats, as well as planned actions in the event of a response or recovery situation.
These updates also typically include a review of any recent enhancements to the Company s defenses and management s progress on its cybersecurity, as well as reports on key performance indicators, test results and related remediation, and recent threats and how the Company is managing those threats.
The full Board receives updates periodically or as needed during the year from the Company s Chief Information Officer and actively participates in discussions with management and amongst themselves regarding cybersecurity risks.
Updates delivered to the full Board typically include discussion of management s actions to identify and detect threats, as well as planned actions in the event of a response or recovery situation.
These updates also typically include a review of any recent enhancements to the Company s defenses and management s progress on its cybersecurity, as well as reports on key performance indicators, test results and related remediation, and recent threats and how the Company is managing those threats.
The full Board receives updates periodically or as needed during the year from the Company s Chief Information Officer and actively participates in discussions with management and amongst themselves regarding cybersecurity risks.
REMOVED
siga20241231_10k.htm 0001010086 Siga Technologies INC false --12-31 FY 2024 true true true false true true 0.0001 0.0001 600,000,000 600,000,000 71,404,669 71,404,669 71,091,616 71,091,616 0.45 0.45 0.60 2 0 5 3 7 4 1 1 0 0 0 0 10 2 3 3 0.5 0.5 http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent http://fasb.org/us-gaap/2024#AccruedLiabilitiesCurrent 0 0 0 0 10 0 1 3 1 0.2 1 1 2 2 3 10 0.6 0.7 http://fasb.org/us-gaap/2024#OtherLiabilities 20,000 0 0 63 5 0 false false false false includes 59,312 awards which were settled in cash.
includes 40,075 awards which were expected to be settled in cash.
As of February 14, 2025, the registrant had outstanding 71,436,927 shares of common stock.
Department of Defense contracts are modified or canceled at the request or requirement of, or SIGA is not able to enter into new contracts to supply TPOXX to, the U.S.
As of December 31, 2024, the contract with BARDA (as amended, modified, or supplemented from time to time, the "19C BARDA Contract") contemplates up to approximately $602.5 million of payments, of which approximately $51.7 million of payments are included within the base period of performance, approximately $519.6 million of payments are related to exercised options and up to approximately $31.2 million of payments are currently specified as unexercised options.
The options that have been exercised as of December 31, 2024, provide for payments up to approximately $519.6 million.
As of December 31, 2024, there are exercised options for the following activities: payments up to $450.2 million for the manufacture and delivery of up to 1.5 million courses of oral TPOXX ; payments up to $51.2 million for the manufacture of courses of IV FDP, of which $20.5 million of payments relate to the manufacture of IV BDS to be used in the manufacture of IV FDP; payments of up to approximately $3.6 million to fund post-marketing activities for IV TPOXX ; and payments of up to $14.6 million for funding of post-marketing activities for oral TPOXX .
The remaining unexercised options specify payments of up to $25.6 million for the manufacture of courses of IV FDP, of which up to $10.2 million of payments would be paid upon the manufacture of IV BDS to be used in the manufacture of IV FDP.
BARDA may choose to exercise any, all, or none of these options in its sole discretion.
To date, BARDA has exercised two of the three IV BDS options and two of the three IV FDP options.